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Mechanisms of Genomic Imprinting
Karl Pfeifer
Laboratory of Mammalian Genes and Development, NICHD/NIH, Bethesda, MD
Imprinted genes represent a curious defiance of normal Mendelian genetics. Mammals inherit two complete sets
of chromosomes, one from the mother and one from the father, and most autosomal genes will be expressed from
both the maternal and the paternal alleles. Imprinted genes, however, are expressed from only one chromosome,
in a parent-of-origin–dependent manner. Because silent and active promoters are present in a single nucleus, the
differences in activity cannot be explained by transcription-factor abundance. Thus, transcription of imprinted
genes represents a clear situation in which epigenetic mechanisms restrict gene expression and, therefore, offers a
model for understanding the role of DNAmodifications and chromatin structure in maintaining appropriate patterns
of expression. Furthermore, because of their parent-of-origin–restricted expression, phenotypes determined by im-
printed genes are susceptible not only to genetic alterations in the genes but also to disruptions in the epigenetic
programs controlling regulation. Imprinted genes are often associated with human diseases, including disorders
affecting cell growth, development, and behavior.
Introduction
The nonequivalence of maternally and paternally con-
tributed genomes was first identified in elegant nuclear-
transfer studies (McGrath and Solter 1984; Surani et al.
1984). Subsequently, uniparental disomies (UPDs), in
which either single chromosomes or parts thereof are
inherited solely through the maternal or the paternal
germlines, have been studied extensively in mice, to iden-
tify regions of the genome that carry imprinted genes
(Cattanach 1986). For example, paternal UPD of the
distal end of mouse chromosome 7 results in early em-
bryonic lethality, a phenotype that can be explained by
either loss of a maternal-specific transcript or the double
dose of a paternal-specific transcript in these animals
(Ferguson-Smith et al. 1991). Likewise, human geneti-
cists have identified, by association of uniparental in-
heritance of these regions with specific diseases, chro-
mosomal regions likely to carry imprinted genes; for
example, paternal UPD of human 11p15.5 (syntenic
with mouse distal 7) is associated with Beckwith-Wie-
demann syndrome (BWS [MIM 130650]) (Henry et al.
1991; Weksberg et al. 1993b). Other diseases clearly
associated with imprinted genes include Prader-Willi
(PWS [MIM 176270]), Angelman (AS [MIM 105830]),
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and Russell-Silver syndromes (MIM 180860) and Al-
bright hereditary osteodystrophy (MIM 103580). Im-
printed genes contribute to language development and
social affiliation (Skuse et al. 1997) and probably to
other complex behavioral phenotypes, including alcohol
preference, schizophrenia, and bipolar affective disorder,
in humans (Nicholls 2000). Finally, disruption in the
monoallelic expression of imprinted genes may be the
most common mutation associated with cancer (Fein-
berg 2000). An excellent compilation and description of
studies demonstrating parent-of-origin effects has been
recently published (Morison and Reeve 1998).
Several approaches have been used to isolate im-
printed genes. These include positional cloning and can-
didate-gene testing to find genes responsible for the UPD
phenotypes in mice and humans (e.g., see Barlow et al.
1991; Lee et al. 1997), as well as genomewide scans
that depend on the differential expression or epigenetic
modification of maternal and paternal alleles of im-
printed genes (e.g., see Hatada et al. 1993; Kaneko-
Ishino et al. 1995; Piras et al. 2000). It has become clear
that imprinted genes are not randomly distributed
throughout the genome but, rather, are often concen-
trated in discrete clusters. Thus, the identification of one
imprinted gene has often led to the rapid determination
that nearby genes are also imprinted. Finally, allele-spe-
cific expression of several genes has been discovered
serendipitously during analysis of their loss-of-function
phenotypes in mouse studies. The paternal-specific ex-
pression of IGF2 (MIM 147470), the first endogenous
gene to be identified as imprinted, was discovered in
this way (DeChiara et al. 1991). The frequency with
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which imprinted genes have been fortuitously identified
in knockout studies suggests that ∼0.1%–1% of all
mammalian genes are imprinted (Barlow 1995). To
date, ∼3 dozen imprinted genes have been identified in
mice and humans.
This review will focus on recent experiments inves-
tigating the molecular basis for monoallelic expression
of genes within two imprinted gene clusters: human
11p15.5/mouse distal 7 (associated with BWS and with
Wilms tumor [MIM 194070]) and human 15q11-q13/
central mouse chromosome 7 (associated with PWS and
AS). Taken together, these studies indicate that mech-
anisms for parent-of-origin–specific gene expression are
likely to vary from gene to gene, since the cell exploits
cis-acting sequences and transcription factors already
involved in determining the cell type–specific patterns
of expression. Thus, dissection of imprinting pathways
contributes to a general understanding of mechanisms
for controlling the expression of nonimprinted genes in
the mammalian cell.
Allele-Specific Expression: A Developmental Process
Imprinting can be considered a multistep developmental
process. First, the chromosome must be marked as to
its parental origin. Presumably, this occurs either during
gametogenesis or in the zygote, prior to fusion of the
two gametes, while the maternal and paternal chro-
mosomes are still physically separate. Second, a parent-
of-origin mark must be stably maintained as the cells
divide and differentiate. The imprint or mark might re-
main identical to the original mark on the gametic chro-
mosomes or may be a secondary derivative of that mark.
Third, a parent-of-origin mark must be recognized by
the transcriptional machinery, so as to result in mono-
allelic expression. Finally, and specific to germ cells, the
mark must be erased and reset. A failure at any of these
steps would result in a loss of imprinting (LOI)mutation.
As described below, there is evidence for mutations in
each of these steps in animal and human disease models.
Establishing the Mark: Imprinting and DNA
Methylation
CpG methylation has received great attention as an ex-
cellent candidate for the genomic-imprinting mark, on
the basis of two very useful properties of the DNAmeth-
yltransferase 1 (DNMT1) enzyme. First, DNMT1 has
been demonstrated to associate with DNA-replication
forks. Second, it shows a strong substrate preference for
hemimethylated DNA. Given the semiconservative rep-
lication of DNA, these two features of the enzyme in-
dicate that DNA, once methylated, will tend to stay
methylated, thus providing a mechanism for the stable
maintenance of an imprint during cell division and dif-
ferentiation (Bestor and Verdine 1994).
Using CpG-sensitive restriction enzymes or bisulfite
sequencing, researchers in many labs have identified
parent-of-origin–specific differences in CpG methyla-
tion in almost all imprinted genes that have been ex-
amined. However, only for three genes—H19 (MIM
103280), IGF2R (MIM 147280), and Snrpn (MIM
182279)—does this methylation fit the strictest criteria
of a genomic imprint—that is, the differences are pres-
ent in gametes and are maintained throughout devel-
opment (Stoger et al. 1993; Tremblay et al. 1995;
Shemer et al. 1997). Furthermore, the functional sig-
nificance of the methylated sequences for each of these
genes is supported by mutational analyses that dem-
onstrate the essential role of these elements in imprinted
expression of linked genes (Wutz et al. 1997; Thor-
valdsen et al. 1998; Yang et al. 1998).
A role for methylation is further supported by the
demonstration that mice deficient in Dnmt1-gene func-
tion show a loss of imprinting at almost all loci tested
(Li et al. 1993; Shemer et al. 1997; Caspary et al. 1998).
The exact phenotype is gene specific, consistent with the
association of methylation with both silent and ex-
pressed loci; for example, the H19 gene, which is nor-
mally methylated on the silent paternal allele, becomes
biallelically expressed after loss of Dnmt1 function. In
contrast, methylation of Igf2R and Igf2 is normally on
the active allele, and Dnmt1-deficient mice fail to ex-
press these genes from either chromosome. These ex-
periments do not distinguish between a role for Dnmt1
function in establishing the gametic imprint, maintain-
ing the mark in somatic cells, or altering gene expression
in response to the real gametic imprint.
Monoallelic expression of at least one gene, Mash2,
proceeds even in the absence of Dnmt1 activity (Cas-
pary et al. 1998; Tanaka et al. 1999). This gene is part
of the human 11p15.5/mouse distal 7 cluster (fig. 1a),
where monoallelic expression of the H19, Igf2, Kvlqt1,
and P57Kip2 genes is dependent on methylation (Li et
al. 1993; Caspary et al. 1998). Perhaps these results
mean only that CpG sequences crucial for imprinting
of Mash2 are less sensitive to the loss of Dnmt1 func-
tion, given compensation by other methyltransferases
still present in the mouse. However, organisms that lack
methyltransferase enzyme activity can still maintain
stable states of gene activation and repression, including
parent-of-origin–specific effects (e.g., see Dalgaard
and Klar 1999; Wolffe and Matzke 1999). Thus,
DNA methylation is not necessarily crucial in genomic
imprinting.
Molecular bases by which methylation can alter tran-
scription patterns are becoming increasingly clear (Ng
and Bird 1999). Methylation can block expression di-
rectly, by interfering with the binding of transcriptional
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Figure 1 Clusters of imprinted genes onmouse distal 7 (syntenic
with human 11p15.5) (a) and human 15q11-q13 (syntenic withmouse
central 7) (b). Transcripts are depicted by arrows, with the direction
indicated if known. Regions showing parent-of-origin–dependent
DNA methylation are shown as CH3. The thickened segments of the
lines represent the AS-IC and PWS-IC elements, as indicated. These
sites are required in cis for normal imprinting on human 15q11-13.
activator complexes, or it may act indirectly, by re-
cruiting the factors that induce repressive chromatin
structures. Methylation is also associated with active
alleles, at several loci. In this case, the methylation is
expected to interfere with recruitment of a transcrip-
tional repressor. The exact role for methylation in mo-
noallelic expression both in setting the genomic imprint
and in altering the patterns of gene expression is best
characterized for the mouse H19/Igf2 locus.
Multiple Roles for Methylation: Imprinting at the
Mouse H19/Igf2 Locus
Understanding the molecular basis for the paternal spe-
cific expression of Igf2 is of long-standing interest in the
field of imprinting. Mouse Igf2 was the first endogenous
gene whose parent-of-origin–specific expressionwas rec-
ognized. In addition, overexpression of IGF2 has been
a favored mechanism for the etiology of both BWS and
Wilms tumor. Overexpression of Igf2 can occur through
paternal UPD, through rearrangements on the maternal
chromosome, or through LOI mutations, in which ex-
pression of the normally silent maternal Igf2 allele is
noted (Ping et al. 1989; Weksberg et al. 1993a; Elliot
and Maher 1994; Joyce et al. 1997).
Igf2 is part of a cluster of imprinted genes whose
organization is well conserved in mice and humans (fig.
1a). Igf2 and its neighbor, the maternal-specific H19
gene, are coregulated. They share enhancers, at least for
expression in several endodermal tissues (Leighton et
al. 1995b) and in skeletal muscle (Kaffer et al. 2000).
These enhancers all lie 3′ of the H19 gene and, thus,
downstream of the Igf2 and the H19 promoters (fig.
2a).
Likewise, the reciprocal imprinting of the Igf2/H19
gene pair is also mechanistically linked. LOI mutations
associated with Wilms tumor generally show biallelic
expression of IGF2, coupled with loss of expression of
H19 from the maternal chromosome (Steenman et al.
1994; Reik et al. 1995; Catchpoole et al. 1997). In mice,
a deletion of the H19 gene and 10 kb of upstream se-
quence that leaves the shared enhancers intact causes
biallelic expression of Igf2 (Leighton et al. 1995a; fig.
2b). Together, these results suggest that silencing of pa-
ternal Igf2might ultimately be dependent on the activity
of the H19 gene, and, thus, attention has been focused
on mechanisms of imprinting at that locus.
Genetic analysis of imprinting of the H19 gene itself
has been greatly facilitated by the finding that relatively
small transgenes carrying the H19 gene, its promoter,
its enhancer elements, and several kilobases of upstream
sequences can mimic the maternal-specific expression of
the endogenous locus (Bartolomei et al. 1993). Deletion
analyses of these transgenes demonstrated that pro-
moter and enhancer sequences required for tissue-spe-
cific and temporally appropriate expression of H19 are
not sufficient for making the transgene maternal-chro-
mosome specific. Rather, sequences encompassing at
least approximately 2 to 4/7 kb upstream of the H19
promoter are necessary to mark the H19 transgene
as paternal in origin (Pfeifer et al. 1996; Elson and Bar-
tolomei 1997; Ainscough et al. 1998; Kaffer et al.
2000) and to induce maternal-specific expression of the
transgene.
Experiments to define differences in the paternal and
maternal chromosomes underline the importance of
these upstream sequences. These sequences are meth-
ylated in sperm but not in oocytes, and the paternal
chromosome remains differentially hypermethylated
throughout embryogenesis (Tremblay et al. 1995).
Thus, this region, H19DMR (differentially methylated
region), appears to carry a methylation imprint. During
development, the hypermethylation on the paternal al-
lele expands from H19DMR to include the H19 pro-
moter and the gene body (fig. 2a). More recently, several
labs have independently identified nuclease-hypersen-
sitive sites inH19DMR that are specific to the maternal
chromosome (Hark and Tilghman 1998; Szabo et al.
1998; Khosla et al. 1999).
The maternal H19 promoter also becomes nuclease
hypersensitive, consistent with the binding of transcrip-
tion factors and activation of expression of the maternal
H19 allele. (Bartolomei et al. 1993; Ferguson-Smith et
al. 1993). Strikingly, no allelic differences in nuclease
hypersensitivity at the Igf2 promoter have been re-
ported, which suggests that both the maternal and pa-
ternal Igf2 promoters might be equally ready for acti-
Figure 2 Effect that mutations in the H19DMR region have on expression of H19 and Igf2. a, Wild-type expression. Most wild-type
cells express only the maternal H19 allele and only the paternal Igf2 allele. Expression of both genes is driven by shared enhancer elements.
Endodermal enhancers (unblackened ovals) and skeletal muscle enhancers (blackened ovals) are ∼8 and ∼24 kb upstream of the H19 promoter,
which is ∼90 kb upstream of the Igf2 promoter. Paternal chromosome–specific CpG methylation is noted in upstream sequences called
“H19DMR” (thickened segments of lines). Differential methylation of this region is observed in sperm and is maintained during the global
methylation changes observed during early embryogenesis. After implantation, the hypermethylation (CH3) spreads to include theH19 promoter
and gene body. The maternal chromosome shows hypersensitivity to nuclease digestion (vertical arrows) in the DMR region and at the H19
promoter, whereas the Igf2 promoter appears to be equally sensitive to digestion on both chromosomes. b, Mechanistically linked imprinting
of H19 and Igf2. The H19D13 allele replaces the H19 gene, including its promoter andH19DMR, with theNeoR gene. The shared endodermal
and mesodermal enhancers are unaffected by this mutation, which, on maternal inheritance, results in biallelic expression of Igf2. c, H19DMR,
necessary to silence paternal expression of H19. H19DDMR removes sequences that are differentially methylated on the paternal chromosome.
When inherited through the paternal germline or removed from the paternal chromosome early during embryogenesis,H19 expression becomes
biallelic. d, Silencing of the paternal H19 allele, mediated by epigenetic changes driven by H19DMR but not directly dependent on DMR
function.WhenDMR sequences are removed from the paternal chromosome only late during embryogenesis,H19 expression remainsmonoallelic.
e, H19DMR, necessary to silence expression of Igf2 from the maternal allele. When inherited through the maternal germline or removed from
the maternal chromosome early during embryogenesis, Igf2 expression becomes biallelic. f, Silencing of the maternal Igf2 allele, directly dependent
on the action of H19DMR. Even when the DMR is removed from the maternal chromosome only late during embryogenesis, Igf2 expression
becomes biallelic. g, H19DMR and transcriptional insulator function. In DMRmove, H19DMR was inserted between the H19/Igf2 endodermal
and mesodermal enhancers. After maternal inheritance of the DMRmove chromosome, H19 expression in skeletal muscle, but not in the liver,
was lost. h, Biallelic expression of Igf2, allowed by moving of the endodermal enhancer elements closer to Igf2, where they are no longer
separated from the Igf2 promoter by the DMR. “Early embryo” (c and e) indicates that deletions were generated in preimplantation embryos.
“Late embryo” (d and f) describes deletions generated in differentiated muscle cells.
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vation but that some other factor prevents enhancement
on the maternal chromosome (Sasaki et al. 1992).
Mice inheriting a deletion of the H19DMR through
the father show loss of imprinting atH19—that is, these
mice are biallelic for expression of H19 (Thorvaldsen
et al. 1998; fig. 2c). Thus, H19DMR acts to silence the
paternal H19 promoter. To address the mechanism of
silencing, H19DMR was flanked with Cre lox sites and
was deleted in a temporally regulated manner, by use
of cell type–specific Cre recombinase transgenes (Sri-
vastava et al. 2000). It was therefore possible to generate
mice that had inherited a wild-type paternal chromo-
some in which H19DMR was deleted either in early
embryos or in differentiated cells (fig. 2c and d). When
H19DMR was deleted from the paternal chromosome
in differentiated cells, the paternal H19 allele remained
silent. However, when a wild-type chromosome is in-
herited through the sperm butH19DMR is deleted early
during embryogenesis, repression of the paternal allele
is lost. Thus,H19DMR’s role in monoallelic expression
is temporary, and its silencing activity is not required
for direct interaction with the transcriptional machin-
ery. Bisulfite-sequencing experiments demonstrate that
H19DMR is required during early embryogenesis, to
direct methylation of the H19 promoter. These changes
are then stably maintained independent of DMR and
probably directly repress the paternal allele. These re-
sults are consistent with earlier experiments, which
showed that the repression of the paternal H19 is ac-
tually a process that proceeds as the embryo develops
(Jinno et al. 1995; Szabo and Mann 1995; Svensson et
al. 1998).
In sum, genetic experiments demonstrate that
H19DMR is necessary to maintain the H19 imprint
during early development and to convert the imprint
into a signal that actually represses the transcriptional
machinery. Molecular studies support the notion that
DMR carries the actual imprint, but genetic studies to
date have not been able to address this issue.
H19DMR is also required for monoallelic expression
of Igf2 (Thorvaldsen et al. 1998; fig. 2e). Its deletion
on the maternal chromosome results in inappropriate
activation of the maternal Igf2 allele. Thus, H19DMR
is also a silencer for Igf2. Strikingly, the mechanism for
silencing of Igf2 is distinct from the mechanism used to
silence paternal H19 (Srivastava et al. 2000; fig. 2e–f).
Deletion of DMR in a cell type–specific manner dem-
onstrates that its presence is continually necessary to
silence the maternal Igf2 promoter, indicating that ma-
ternalH19DMR and/or bound proteins interact directly
with the transcriptional machinery, to block expression
of maternal Igf2. One model to explain H19DMR’s
action in suppressing maternal Igf2 expression posits
that it functions as a transcriptional insulator. On the
maternal chromosome, the insulator prevents activation
of the Igf2 promoter by the distal enhancers. On the
paternal chromosome, the methylation imprint inacti-
vates the insulator, allowing activation of the paternal
Igf2 allele.
The hallmark of a transcriptional insulator is its abil-
ity to prevent activation of a promoter, in a strictly
position-dependent manner. An insulator prevents tran-
scription only when juxtaposed between a promoter and
the enhancers on which that promoter depends for its
activation. The ability of H19DMR sequences to act as
a transcriptional insulator has been demonstrated in
vivo by use of transgenes inserted at heterologous po-
sitions in the chromosome (Hark et al. 2000) and by
manipulation of the H19/Igf2 locus itself (Kaffer et al.
2000; fig. 2g). In the latter experiment, DMR was re-
moved to a position downstream of the H19 gene, be-
tween the endodermal and skeletal muscle enhancer el-
ements. This construct, DMRmove, thus places the
putative insulator between the H19 promoter and the
muscle enhancers and thereby mimics the topology of
the Igf2 locus (fig. 2g). With maternal inheritance, ac-
tivation of H19 in skeletal muscle but not in liver was
blocked, consistent with the presence of insulator ac-
tivity on the H19DMR insert. With paternal inheri-
tance, the relocated H19DMR is methylated, and its
insulator function abrogated (C. R. Kaffer and K. Pfei-
fer, unpublished observations).
The ability ofH19DMR sequences to act as insulators
has also been demonstrated in vitro by use of integrated
(Bell and Felsenfeld 2000; Hark et al. 2000; Kaffer et
al. 2000) and episomal (Kanduri et al. 2000) minigene
constructs. The ability of transfected DNA constructs
to mimic expression patterns and chromatin confor-
mations of the maternal locus is good evidence that
imprinting at H19/Igf2 is solely a paternal marking of
the chromosome.
The molecular basis for paternal-specific inactiva-
tion of the insulator is provided by biochemical analyses
that show that binding of the CCCTC-binding factor
(CTCF) protein to DMR sequences is inhibited by CpG
methylation of the protein’s recognition sites (Bell and
Felsenfeld 2000; Hark et al. 2000). CTCF is a tran-
scription factor that has been demonstrated elsewhere
to play a role in insulator activity at the chicken b-globin
locus (Bell et al. 1999). That CTCF actually plays a role
in the cell is strongly supported by in vivo footprinting
results that demonstrate maternal chromosome–specific
CTCF (Szabo et al. 2000).
Together, these results present a conceptually simple
model for imprinting at H19/Igf2. The maternal chro-
mosome represents the default or unimprinted state.
The H19 promoter is active, as is a transcriptional in-
sulator that prevents activation of the Igf2 promoter by
the shared enhancer elements. The paternal chromo-
some is marked or imprinted at DMR, and this imprint
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has two functions. First, it directs further epigenetic
modification of the H19 promoter, which blocks its ac-
tivity. Second, the methylation prevents binding of
CTCF protein and thus prevents activation of the in-
sulator element, thereby permitting enhancer-mediated
activation of the Igf2 promoter. Experiments that in-
troduced chromosome 11 into mouse cells demon-
strated that these mechanisms for transcriptional reg-
ulation are likely to be conserved in humans (Gabriel
et al. 1998b).
LOI Mutations at Human IGF2
Biallelic expression of IGF2 without deletion or rear-
rangement on either chromosome is frequently associ-
ated with BWS and with Wilms tumor. In some cases,
this LOI at IGF2 is associated with normal, maternal-
specific expression of H19 (Brown et al. 1996; Joyce et
al. 1997). In other cases, LOI at IGF2 is associated with
inappropriate silencing and hypermethylation of both
H19 alleles (Steenman et al. 1994; Reik et al. 1995;
Catchpoole et al. 1997). How can these LOI phenotypes
be viewed, in light of the mouse studies just described?
The first LOI phenotype—biallelic IGF2/normalH19
expression—does present in the mouse, in which the
maternal chromosome is inherited in its wild-type form
but in which an H19DMR deletion occurs late during
embryonic development (fig. 2f). Thus, by analogy with
the mouse, these patients with LOI may be better de-
scribed as having loss of insulation rather than im-
printing. The interesting issue is the molecular basis for
loss of insulation in these patients. In mice, this phe-
notype is caused by a deletion of the insulator element.
In most patients, no chromosomal abnormalities or ge-
netic alterations are observed. Intriguingly, however,
LOI can be associated with chromosomal inversion/de-
letions in the BWSCR1 region, which spans the
KVLQT1 (KCNQ1) gene, several hundred kilobases
upstream of IGF2 (Mannens et al. 1994; Hoovers et al.
1995; fig. 1a).
Mouse studies predict that the maternal Igf2 pro-
moter is ready for activation but is silent because of the
lack of activation by enhancer elements. If this is also
the case for human IGF2, there are only two formal
explanations for the ability of a mutation to permit
activation of the maternal IGF2. In the first case, in-
sulator function ofH19DMR is unaffected, and the nor-
mal IGF2 enhancers remain unable to activate the
maternal IGF2 promoter. Then the effect of BWS mu-
tations must be to somehow “create” a new enhancer
element for IGF2. To explain molecular data, this new
enhancer would need to activate IGF2 in the appro-
priate tissues and at levels like that of the endogenous
enhancer. Such a mutation was, in fact, engineered in
the mouse by removal of the normal endodermal en-
hancers to a position midway between H19 and Igf2
and, thus, on the proximal side of the Igf2 promot-
er, relative to the H19DMR insulator (Webber et al.
1998; fig. 2h). The alternative—and, I think, more
likely—scenario is that theH19DMR insulator function
is abolished in these patients with LOI. This loss of
insulation then allows expression of maternal IGF2 to
be driven by the normal enhancers. In this scenario, LOI
occurs via an epigenetic or genetic alteration in se-
quences required to act with the H19DMR to organize
the maternal IGF2 into a transcriptionally silent do-
main. Perhaps the organization of the locus into do-
mains of expressed and unexpressed genes uses paired
insulator/boundary domains like the scs/scs′ system de-
scribed in Drosophila (Udvardy 1985; Kellum and
Schedl 1991, 1992). Further directed mutagenesis in
mice, mimicking the translocation chromosomes of pa-
tients with BWS, will help elucidate the true nature of
these mutations.
The second type of LOI mutation in BWS shows bial-
lelic IGF2 associated with loss of expression of the ma-
ternal H19 gene (Brown et al. 1996; Joyce et al. 1997).
By analogy with the mouse, this phenotype would be
more usefully described as gain of imprinting, because
the patient has, in effect, two imprinted chromosomes.
No such phenotype is observed in mice, and it is hard
to imagine how to generate such a phenotype via genetic
alterations. Bestor and Tycko (1996) have described an
epigenetic mechanism that could create de novo meth-
ylation during DNA synthesis. When imprinted do-
mains pair during mitosis (LaSalle and LaLande 1996),
strand exchange that occurs infrequently betweenmeth-
ylated and nonmethylated sequences will present hemi-
methylated sites to the DNMT1 enzyme. DNMT1
maintenance activity thus is used by the organism to
create de novomethylation, given an alreadymethylated
template. Such a phenomenon has been described in the
fungus Ascobulus (Colot et al. 1996).
A Second Imprint on 11p15.5?
One clear finding of both mouse and human studies is
that imprinting at the H19/IGF2 locus can be mecha-
nistically separated from imprinting of other genes in the
cluster. First, the effect of deletion of the H19 gene and
H19DMR is restricted to the H19, Igf2, and Ins2 loci;
the deletion has no effect on imprinting of Mash2,
Kvlqt1, or p57Kip2 (Leighton et al. 1995a; Caspary et
al. 1998). Second, the effects of LOI at IGF2 are, in
most cases, restricted to that gene and to H19 (Reik et
al. 1995). Finally, genes in the distal 7 cluster are dif-
ferentially affected by Dnmt1 loss-of-function muta-
tions. Together, these findings suggest that there are
probably additional cis-acting imprinting centers (ICs)
at human 11p15.5/mouse distal 7. The disruption of the
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KVLQT1 locus in multiple cases of BWS suggests that
KVLQT1 may harbor these elements (Lee et al. 1997).
Two labs have identified a region nearKVLQT1 exon
10, KvDMR, that is hypermethylated specifically on the
maternal chromosome (Lee et al. 1999; Mitsuya et al.
1999; Smilinich et al. 1999). Preliminary evidence sup-
ports the notion that this methylation is a true imprint,
in that it appears to be oocyte specific and not acquired
developmentally in response to allele-specific transcrip-
tion. The functional significance of KvDMR is not yet
clear. LOI at the site is associated with a number of
cases of BWS, including cases that also show LOI at
IGF2 but, more generally, cases that are normal for
IGF2 function. Lee et al. (1999) speculate that KvDMR
might be a regulatory site working analogously to the
H19DMR,whose methylation permits expression of the
downstream KVLQT1 and p57KIP2 promoters.
If independent mechanisms determine imprinting for
discrete clusters of genes within the 11p15.5/distal 7
supercluster, it remains puzzling why the clusters are
then grouped in the first place. One explanation is that
the region contains sequences that make the whole re-
gion permissive for imprinting but that individual IC
centers are further necessary to implement the imprint.
This description does not account for the ability of rel-
atively small H19 transgenes to direct their own im-
printing at a wide range of chromosomal integration
sites. Imprinting of transgenes has not been demon-
strated for other genes in the cluster.
Imprinting at a Distance: 15q11-q13
A second well-characterized cluster of imprinted genes
is located on human chromosome 15q11-q13 (central
mouse 7) (fig. 1b). PWS and AS are two clinically distinct
neurobehavioral disorders that are each most commonly
caused by an identical 4-Mbp deletion of this region.
However, the deletion is always paternal in origin for
PWS but maternal in origin for AS (for reviews, see Jiang
et al. 1998; Nicholls et al. 1998). The maternally ex-
pressed UBE3A gene maps toward the telomeric end of
the deletion, and loss of UBE3A is likely to explain AS
(Nakao et al. 1994; Rougeulle et al. 1997; Vu and Hoff-
man 1997). At least six paternal-specific transcripts—
ZNF127, NDN, SNURF/SNRPN, PAR5, IPW, and
PAR1—have been identified, and all map to the cen-
tromeric end of the deletion (Ozcelik et al. 1992; Sutcliffe
et al. 1994; Wevrick et al. 1994; MacDonald and Wev-
rick 1997; Sutcliffe et al. 1997; Gray et al. 1999; Jong
et al. 1999; fig. 1b). More recently, eight novel imprinted
transcripts have been mapped to the locus, but their
regulation by the IC mutations (see below) has not yet
been tested (Lee and Wevrick 2000). The mapped im-
printed genes span 12 Mb. A region in the middle of
the cluster that encompasses the SNURF/SNRPN pro-
moter is hypermethylated on the maternal chromosome
at all stages of development and is therefore a good
candidate for a gametic imprint (Sutcliffe et al. 1994;
Glenn et al. 1996). This imprint is conserved in the
mouse (Shemer et al. 1997; Gabriel et al. 1998a).
One genetically interesting class of patients with PWS
have biparental inheritance of chromosome 15, but both
chromosomes behave maternally—that is, are hyper-
methylated at the SNURF/SNRPN locus and express
only UBE3A (Reis et al. 1994; Buiting et al. 1995; Sai-
toh et al. 1996). In rare patients with PWS who have
microdeletions causing this imprinting defect, the PWS
imprinting center (PWS-IC) has been mapped to a 4.3-
kbp region spanning the SNURF/SNRPN promoter and
coincident with the methylation imprint (Ohta et al.
1999a; fig. 1b). These PWS-IC mutations can be trans-
mitted silently over multiple generations, with the phe-
notype apparent only when the imprint needs to be reset
from maternal to paternal. Thus, it has been suggested
that, at this locus in humans and in mice, PWS-IC con-
trols switching in the male germline (Yang et al. 1998).
However, recent experiments demonstrate thatPWS-IC,
in both humans and mice, is required for maintainance
of the paternal identity of the chromosome during early
embryogenesis (Bielinska et al. 2000).
At a superficial level, PWS-IC thus resembles
H19DMR. Methylation of either element results in si-
lencing of linked genes—either SNURF/SNRPN and
other paternal genes at 15q11-q13 or H19 at 11p15.5.
In both cases, they are certainly required during early
embryogenesis, and probably also in germ cells, to mark
the silent chromosome. Of course, PWS-IC is able to
silence transcription of genes that are orders of mag-
nitude distant, relative to the effects of H19DMR. The
mechanism by which the silent state is transmitted over
such long distances is not understood. The overlap of
the IC with SNURF/SNRPN is intriguing, and it is not
clear whether this is coincidence or whether expression
of that promoter and/or the RNA product itself are
somehow required to keep the paternal chromosome
transcriptionally active. However, at least some inser-
tional mutations at the SNURF/SNRPN locus do not
disrupt imprinting (Yang et al. 1998; Tsai et al. 1999).
The ability of the imprint to activate maternal
UBE3A is perhaps explained by the recent discovery of
a paternally expressed antisense transcript overlapping
UBE3A but proximal to it, relative to PWS-IC (Rou-
geulle et al. 1998; fig. 1b). The authors who reported
this discovery proposed that UBE3A imprinting might
be the indirect effect of paternal-specific expression of
the antisense transcript. In keeping with this hypothesis,
UBE3A is biallelic in all tissues in which the antisense
tissue is not expressed, but it is monoallelic in the brain,
where the antisense transcript is expressed.
The previous discussion of imprinting at 15q11-q13
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is oversimplified, however, because it has not accounted
for the presence of an AS-IC in addition to PWS-IC.
This 1.15-kb element is ∼40 kb upstream of the SNURF/
SNRPN promoter (fig. 1b) (Ohta et al. 1999b) and is
defined by the microdeletions that cause maternally in-
herited chromosomes to show a paternal phenotype—
that is, hypomethylation at the SNRPN promoter, ex-
pression of paternal transcripts, and loss of maternal-
specific transcription of UBE3A. This situation appears
to be very different from the H19/Igf2 system, in which
it is presumed that the chromosome is imprinted in only
one germline and passes through the other unmarked.
Several models describe mechanisms for gamete-spe-
cific imprinting events at 15q11-q13 (Buiting et al.
1995; Dittrich et al. 1996; Burger et al. 1997; Ohta et
al. 1999a). One unifying model proposes that the role
of both IC elements is to regulate expression of pater-
nal-specific genes (Brannan and Bartolomei 1999).
PWS-IC is a cis-regulatory element required for acti-
vation of the paternal expression pattern, possibly via
its role in initiating or maintaining transcription of
SNURF/SNRPN. Thus, loss of PWS-IC prevents acti-
vation of the paternal program. In the female germline,
the imprint, which is dependent on some transcript or
sequence from AS-IC, is established at the SNURF/
SNRPN promoter. This imprint prevents SNURF/
SNRPN transcription and, thereby, halts the rest of the
paternal program. As predicted by this model, deletion
of PWS-IC is epistatic to deletion of AS-IC.
Summary
Although imprinting remains largely mysterious, recent
experiments have made considerable progress in eluci-
dating some of the mechanisms for monoallelic expres-
sion of imprinted genes. These results indicate that, al-
though DNA methylation plays a crucial role, its direct
effect on transcription will vary from locus to locus. At
the H19/Igf2 locus, methylation represses transcription
of the paternal H19 allele by directly blocking the ac-
tivation of the H19 promoter but activates expression
of Igf2 by its simultaneous inactivation of a transcrip-
tional insulator. On human 15q11-q13, methylation
appears to directly block activation of the maternal
SNURF/SNRPN promoter, perhaps analogous to its ef-
fect on paternal H19. However, it activates UBE3A ex-
pression, possibly indirectly, by blocking expression of
an antisense RNA. These examples of imprinting effects
on promoter activation, insulator function, and long-
range chromatin structure suggest that imprinting has
evolved in the mammal by using conventional mecha-
nisms of transcriptional regulation. Thus, through clever
engineering, the cell is able to use methylation imprints
as both positive and negative signals. Dissecting mono-
allelic expression pathways will therefore contribute to-
ward an understanding of normal gene regulation and
of the molecular basis for diseases associated with dis-
regulation at imprinted loci.
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